GlassScriptPhysician profile
Joel K Jager
NPI 1417976671
$661.35
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.12 · 2020: $182 · 2021: $419.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $147.29 | 2021 | |
| Amgen INC. | $130.53 | 2019-2021 | |
| Allergan, INC. | $63.66 | 2020 | |
| Dexcom, INC. | $59.70 | 2021 | |
| Paratek Pharmaceuticals, INC. | $46.75 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $41.47 | 2021 | |
| Pfizer INC. | $35.15 | 2021 | |
| Abbott Laboratories | $21.15 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.50 | 2021 | |
| Sunovion Pharmaceuticals INC. | $16.72 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.87 | 2021 | |
| Esperion Therapeutics, INC. | $14.84 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $12.87 | 2020 | |
| Glaxosmithkline, LLC. | $12.43 | 2021 | |
| Lilly USA, LLC | $12.27 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $11.15 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Jager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.